Researchers have successfully created a novel biomaterial that can be seeded with insulin-producing beta cells. Implantation of the beta cell-seeded biomaterial reversed diabetes in a mouse model by effectively normalizing glucose levels and significantly increasing survival. The research results were presented Monday, March 19, at ENDO 2018, the annual 100th meeting of the Endocrine Society...
- Endocrine News
- Practice
- Diabetes Research Articles
- Products and Technological advancements in Endocrinology
ENDO 2018: Wearable Heart Rate Monitor Could Signal Low Blood Sugar in Type 1 Diabetes
A wearable medical patch measuring the beat-to-beat variation in heart rate is a promising device for the early detection of hypoglycemia, or low blood sugar, in type 1 diabetes, according to the researchers who tested the new monitor. Results of their preliminary study were presented Saturday at ENDO 2018, the Endocrine Society’s 100th annual meeting...
- Diabetes Research Articles
- Product / Technology
- Products and Technological advancements in Endocrinology
FDA Approves New Continuous Glucose Monitoring System with Predictive Algorithm Technology
The U.S. Food and Drug Administration (FDA) has approved a new continuous glucose monitoring (CGM) system for people with diabetes ages 14 to 75 years. Medtronic is marketing the system as Guardian Connect, the first smart standalone CGM system to help people with diabetes stay ahead of high and low glucose events. The Guardian Connect...
- Cardiometabolic
- Diabetes Research Articles
- Product / Technology
- Products and Technological advancements in Endocrinology
Late-breaking exploratory analysis from the CANVAS Program presented at the American College of Cardiology’s 67th Annual Scientific Session The results of recent analysis showed that canagliflozin significantly reduced the risk of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) at high CV risk. This exploratory analysis from...
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
Program aims to advance knowledge in type 1 diabetes with support for research projects over three years The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli Lilly and Company have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020. The program, which began in 2015,...
As obesity and diabetes rates reach epidemic proportions, a presentation at ENDO 2018 explains why we eat what we eat. We talked with Josephine M. Egan, MD, for a taste of what you can expect from her talk entitled, “Endocrinology of the Tongue.” On Monday afternoon, March 19, Josephine M. Egan, MD, a senior investigator...
Endocrine Society, ADA, AACE, AADE Strongly Disagree with ACP’s Recent Diabetes Statement
Together, the Endocrine Society, the American Diabetes Association (ADA), the American Association for Clinical Endocrinologists (AACE), and the American Association of Diabetes Educators (AADE) strongly disagree with the American College of Physicians’ (ACP’s) proposed new guidance that suggests higher blood glucose targets for people with type 2 diabetes. While there is agreement on individualization of...
Parental Diabetes Abrogates Ethnic Disparities in Glucoregulation, Study Finds
People whose parents have type 2 diabetes see no ethnic disparities in how they regulate glucose or whether they get type 2 diabetes themselves, according to a study recently published in The Journal of Clinical Endocrinology and Metabolism. A study reported by Ebenezer Nyenwe, MD, FWACP, FACP, FACE as part of a research project directed...
Diabetes Research Articles
Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.
